Double Click 728 x 90
Double Click 900 x 250

Dr Tahir Shamsi says passive immunisation can treat coronavirus patients

Atta Ur Rehman KhanWeb Editor & Columnist

20th Mar, 2020. 09:49 pm
Double Click 160 x 600
Dr Tahir Shamsi

Dr Tahir Shamsi, the head of National Institute of Blood Diseases said, “The body of a COVID-19 patient creates antibodies to fight off the virus. These antibodies in the blood of a recovered patient could be used to boost the immunity of the newly infected people.”

According to the details, Top hematologist and transplant surgeon of Pakistan said that the blood of recovered patients of  coronavirus– the mysterious respiratory illness caused by the novel COVID-19 which could be used to slow the spread of the deadly contagion which has killed more than 10,000 people and affected 254,801 others worldwide.

“We can save precious lives using this technique,” Dr Shamsi said while adding that the National Institute of Blood Diseases is fully equipped to successfully use this technique. “Doctors have saved hundreds of lives with the help of this technique in China since February,” he added.

While talking to the newspaper he further said, “A vaccine works by training the immune system to recognise and combat pathogens – either viruses or bacteria – by creating antibodies in the blood. And when the pathogens enters the body, the antibodies already present in the blood successfully fight it off.”

US approves usage of Hydroxychloroquine as #COVID19 medicine: Trump

Earlier on March 19, US President said, a drug currently used as an antimalarial, hydroxychloroquine would be made available almost immediately to treat coronavirus.

According to the details, Trump, speaking at a news conference, pointed to efforts on Gilead Sciences Inc’s experimental antiviral drug Remdesivir and the generic antimalarial drug hydroxychloroquine, saying he had called on the U.S. Food and Drug Administration to streamline its regulatory approval process.


Double Click 300 x 250

Download BOL News App for latest news